What a great surprise , RHT has breakthrough disease diagnostics rolling out at massive scale , it now has potential disease treatments , what else is this company not telling us ?$85 mill market cap compared to PYC $450 million??? re rate is way over due.
Antisense Oligonucleotides R&D Project (for the treatment Liver Diseases)
Ann: R&D Update - Molecular Medicine ASO Project, page-8
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.46M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 327025 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.8¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.12pm 15/11/2024 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable